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Recognizing proteins via the production of highly specific monoclonal antibodies (mAbs) is crucial to identifying proteins for 
proteomic research. However, traditional mAb generation is time-consuming with low efficiency. In this study, we assessed 
the high throughput method of producing mAbs by immunizing mice with multiple antigens in order to obtain hybridomas 
against these multiple antigens in one cell fusion. We selected eight proteins that play important roles in human physiological 
or pathological processes. These proteins were mixed and simultaneously administered to one mouse. We observed the im-
munizing period for 10 d, and determined the effect of liquid medium and semi-solid medium in hybridoma generation. As a 
result, all eight immunogens induced antibodies in the immunized mouse in one cell fusion, we obtained hybridomas specific 
to all eight proteins by enzyme-linked immuno sorbent assay (ELISA) screening, hybridomas against five out of eight showed 
specific positive in Western-blotting assays. This indicates that we generated mAbs specific to eight proteins in one cell fusion, 
greatly increasing the efficiency of mAb generation. Furthermore, we observed that hybridomas selected from the liquid me-
dium and semi-solid medium showed different reactivity to antigens. Our study established high-throughput and time-saving 
methods for production of mAbs. These results provide alternative approaches for increasing the efficacy of mAb generation. 
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Through the development of proteomics research, thousands 
of proteins can be identified by antibodies (Abs) for protein 
separation and enrichment, functional verification, analysis 
of protein-protein interactions, recognition of post-transla- 
tional modifications and so on [1–3]. Therefore, Abs are 
becoming indispensable reagents in protein research. Tradi-
tional antibody production is time-consuming and ineffi-
cient. Numerous attempts to increase the speed of mono-
clonal antibody (mAb) generation and throughput have been 
reported. Ning et al. [4] immunized mice with fractioned 
plasma proteins and identified the corresponding antigens 
by immunoprecipitation/mass spectrum. Ju et al. [5] im-
munized mice with fractionated mitochondrial proteins and 
identified the mAb specificity using cDNA expression li-
brary screening combined with Mass spectrum. Some re-
searchers immunized mice with a protein mixture and 
screened mAb specificity by microarray [6–8] and flow 
cytometry analysis [9]. Other non-hybridoma approaches 
such as target-selective joint polymerase chain reactions [10] 
and phage display [11,12] have also been reported, however, 
these methods are based on antibody repertoire rather than 
inducement by immunization.  
For this study, we used a mixture of eight physiologically 
or pathologically relevant proteins with low pairwise simi-
larity to simultaneously immunize mice. As a result, we 
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obtained positive hybridomas against all the immunized 
proteins at 10 days post immunization. We collected 
mono-specific antibodies against five antigens demonstrated 
in both ELISA and Western-blotting assays. Our study may 
establish a high throughput platform for mAb generation to 
meet the increasing demand for antibodies in protein-related 
research. 
1  Materials and methods  
1.1  Protein expression and purification  
Eight proteins were selected for immunization: tumor pro-
tein p53 (TP53, UniProt ID: P04637), c-myc (UniProt ID: 
P01106), S100 calcium binding protein A8 (S100A8, Uni-
Prot ID: P05109), S100 calcium binding protein A9 
(S100A9, UniProt ID: P06702), pCAF (UniProt ID: 
Q92831), Calcitonin (PCT, full length named PCT-1, trun-
cated fragment from 52 amino acid (Aa) to the C-terminal 
named PCT-2, UniProt ID: P01258), and protein tyrosine 
phosphatase PTEN (PTEN, UniProt ID: P60484). Gene 
encoding pCAF was constructed with vector pET-28a(+) 
(Novagen, Germany), while others were constructed with 
the vector pET-32a(+) (Novagen). The restriction enzyme 
of vectors PCT-1, PCT-2, TP53, c-myc and pCAF are EcoR I 
and Xho I, and the restriction enzyme of vectors S100A8, 
S100A9 and PTEN are BamH I and Xho I. Proteins were 
expressed in Escherichia coli BL21 (DE3) strains by iso-
propyl β-D-1-thiogalactopyranoside (IPTG) induction. The 
E. coli was collected by centrifugation and resuspended 
with binding buffer (20 mmol L1 sodium phosphate, 500 
mmol L1 NaCl, 2040 mmol L1 imidazole, 1% Triton 
X-100, pH 7.4). The samples were treated by sonication for 
about 10 min and centrifuged, and the supernatant was then 
collected and purified with Ni SepharoseTM 6 Fast Flow (GE 
Healthcare, USA) according to the manufacturer’s instruc-
tions as follows: the column was washed with distilled wa-
ter five times the column’s volume, then balanced with at 
least five times the column’s volume of binding buffer; the 
sample was repeatedly loaded into column three times, and 
then washed with 510 column volumes of binding buffer; 
the sample was finally eluted with elution buffer (20 mmol 
L1 sodium phosphate, 500 mmol L1 NaCl, 50500 mmol 
L1 imidazole, 1% Triton X-100, pH 7.4). The purified pro-
teins were analyzed by sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE).  
To avoid the selection of mAbs against the protein tags, 
all proteins were expressed in the pGEX-4T-1 vector with a 
GST tag that was used for Ab screening. The GST-tagged 
protein was purified as follows: E. coli was collected by 
centrifugation and resuspended with lysis buffer (50 mmol 
L1 Tris-HCl pH 8.0, 0.2 mmol L1 EDTA, 100 mmol L1 
NaCl, 1% Triton X-100, 1 mmol L1 DTT, 100 μg mL1 
PMSF). The samples were treated by sonication for about 
10 min and centrifuged, the pellet was collected and washed 
with lysis buffer containing 1, 2 and 4 mol L1 Urea, re-
spectively, the pellet was collected as the inclusion body 
after centrifugation and dissolved by lysis buffer containing 
8 mol L1 urea, then analyzed by SDS-PAGE. 
1.2  Immunization and production of mAb 
Eight purified His-tagged proteins were mixed with 10 μg 
each, emulsified with Freund’s complete adjuvant and were 
immunized to mice simultaneously. After 10 d, mice were 
boosted with half amount (5 μg each) of the same antigens, 
emulsified with Freund’s incomplete adjuvant. Three days 
after boosting, spleen cells of immunized mice were fused 
with myeloma partner Sp2/0 cells following standard pro-
tocols [4]. A portion of the fusion cells from the 10-day 
immunization were cultured in a liquid medium and the rest 
were cultured in a semi-solid medium to compare the effi-
cacy of hybridoma generation in each medium. 
1.3  ELISA  
1.3.1  Antibody titer determination  
The eight GST-tagged proteins were diluted to 1 μg mL1 
by coating buffer (Na2CO3, 1.59 g; NaHCO3, 2.93 g; NaN3, 
0.2 g, dissolved in 1 L distilled water), separately coated to 
96-well plates with 100 μL/well and stored at 4°C overnight. 
The coated 96-well plates were washed three times with 
phosphate balanced solution with 0.05% tween-20 (PBST), 
then blocked with 5% skim milk at 37°C for 1 h, and 
washed again with PBST three times. Anti-serum from im-
munized mice underwent 100-fold dilution and then 
three-fold serial dilutions. The diluted sera were added to 
the antigen-coated plate as the primary antibody, incubated 
at 37°C for 1 h, and then washed with PBST. HRP-    
conjugated goat anti-mouse IgG (Jackson, USA) was dilut-
ed and added to the plates according to the instructions for 
use. After the plates were incubated at 37°C for 30 min, 
TMB chromogen solution (Sigma, USA) was added and the 
reaction was stopped using 0.5 mol L1 H2SO4. The plates 
were finally read at 450 nm using a micro-plate reader. 
1.3.2  Antibody screening 
Hybridomas were selected using two rounds of screening. 
In the first round screening, equal volumes of eight 
GST-tagged proteins (1 μg mL1, described in “Antibody 
titer determination”) were mixed and the mixture was used 
to coat 96-well plates with 100 μL/well and stored at 4°C 
overnight. The coated plates were washed and blocked as 
described. The supernatant of hybridoma was added to the 
antigen-coated plates as the primary antibody and was 
treated following steps described previously. The positive 
clones were selected in the second round screening. In the 
second round screening, eight GST-tagged proteins (1 μg 
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mL1, described in “Antibody titer determination”) were 
used to separately coat 96-well plates with 100 μL/well and 
stored at 4°C overnight. Supernatant of Hybridomas was 
added to the antigen-coated plates as the primary antibody 
and treated following the same procedure as above.  
1.4  Semi-solid medium 
The medium was made using 4% methyl cellulose (Sigma) 
in triple-distilled water that was dissolved and autoclaved, 
then mixed with an equal volume of 2×RPMI 1640 (Hy-
clone, USA) basal liquid medium and stirred for 34 d and 
stored at 4°C. When used for cell culture, the medium was 
supplemented with 20% fetal bovine serum. Hypoxanthine-   
aminopterin-thymidine (HAT, Sigma) and feeder cells were 
mixed with fusion cells and poured into dishes. After cul-
turing for about one week, the clones were visible and 
transferred to 96-well plates and kept in liquid media for 
ELISA detection. 
1.5  Western blotting 
Eight GST-tagged proteins were separately loaded on 
SDS-PAGE gel and electrophoretically transferred to a 
PVDF membrane. The membrane was incubated with su-
pernatant of hybridoma that was selected based on screen-
ing via two rounds of ELISA detection described above. 
Membranes were incubated at 37°C for 2 h and washed with 
PBST then incubated with HRP-conjugated goat anti-mouse 
IgG (Jackson) at 37°C for 1 h. The signal was detected us-
ing an ECL Western-blotting kit (Pierce, USA). 
2  Results 
2.1  Protein expression and purification 
All eight recombinant proteins were expressed in E. coli, 
purified, and analyzed by SDS-PAGE. All eight His-tagged 
proteins used for immunizing and GST-tagged proteins for 
Ab screening are presented in Figure 1. All proteins ex-
pressed correct molecular weight and the purity of each 
purified protein was >90% according to analysis by the 
“Quantity One” software (Bio-Rad, USA). Homologies of 
any two antigens are listed in Table 1. PCT-1 and -2 have a 
higher homology (64%) because they share a common 
amino acid sequence but all other proteins’ homology (Aa 
sequence) is 34%.  
2.2  Antibody titer determination 
Antibody titer after immunization was determined by limit-
ing dilution method using the corresponding GST-tagged 
proteins. The highest dilution of anti-serum with positive 
results is listed in Table S1 in Supporting Information and 
Table 1  The amino acid sequence homology between any two of the 
eight proteins (%) 
 c-Myc pCAF PCT-1 PCT-2 PTEN S100A8 S100A9 TP53 
c-Myc  25 23 26 15 20 21 12 
pCAF 25  34 31 15 15 18 21 
PCT-1 23 34  64 16 23 16 22 
PCT-2 26 31 64  18 9 9 24 
PTEN 15 15 16 18  23 18 16 
S100A8 20 15 23 9 23  28 19 
S100A9 21 18 16 9 18 28  22 
TP53 12 21 22 24 16 19 22  
 
 
Figure 1  SDS-PAGE analysis of eight purified recombinant proteins. 
The gel is composed of 5% stacking gel and 12% separating gel, after 
electrophoresis, the separating gel was stained with Coomassie brilliant 
blue R-250. The left lane in each picture is protein standards. A, 
His-tagged purified proteins. B, GST-tagged purified proteins. 
the lg of highest dilution ratio is shown in Figure 2. The 
results showed all eight immunized antigens induced spe- 
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Figure 2  Antibody titer after immunization was determined by limiting 
dilution method, and detected by ELISA. The titer was indicated in lg of 
highest dilution ratio with positive result. 
cific antibodies in serum from immunized mice, but the 
antibody titer against each protein is different, S100A9 and 
S100A8 induced higher antibody titer while c-myc and 
PTEN induced the lowest antibody titer. 
2.3  Antibody screening by ELISA assay 
2.3.1  The first screening 
After cell fusion, hybridomas were screened with a mixture 
of eight GST-tagged proteins. Two thousand two hundred 
and fifty-six wells (hybridomas) were tested in total and 129 
of them showed positive results in the first ELISA screening 
(Table 2).  
2.3.2  The second screening  
The positive wells (hybridomas) in the first screen were 
further selected in the second screening using eight 
GST-tagged proteins to confirm the corresponding antigen 
of the hybridomas. One hundred and twenty-nine wells (hy-
bridamas) from the first screen were tested, 87 of which 
showed positive in different reactive patterns. Among the 
87 hybridomas, 29 were mono-specific to single protein, 50 
were reactive to two proteins, two were reactive to three 
proteins, one was reactive to four proteins, one was reactive 
to five proteins, one was reactive to six proteins, one was 
reactive to seven proteins, and two were reactive to all the 
eight proteins (Table S2 in Supporting Information), the 
optical density value of all 87 clones and their reactivity are  
Table 2  Summary of detected well number and positive well number in 
two rounds of ELISA assay 
  
Positive wells in 
the 1st screening 
Positive wells in 
the 2nd screening 
Total detected wells 2256 129 87 
Wells from liquid medium 1880 103 78 
Wells from semi-solid medium 376 26 9 
listed in Table S5 in Supporting Information. The number of 
positive hybridomas per antigen is illustrated in Figure 3. 
As the results show, S100A8 and S100A9 account for the 
largest number of positive hybridomas; moreover, a signifi-
cant portion of these hybridomas are cross-reactive to both 
S100A8 and S100A9 proteins. Notably, pCAF induced 
more mono-specific hybridomas.  
Results of partial mono-specific clones (hybridomas) in 
the second ELISA screening were collected (Table S3 in 
Supporting Information) and shown in Figure 4. From the 
results, the corresponding antigens of different hybridomas 
are easily understood. For example, the corresponding anti-
gen of Clone 1 is c-Myc, the corresponding antigen of 
Clone 2 is TP53 and so on. Clone 6 reacted to PCT-1 and 
PCT-2, indicating that its corresponding antigen is the 
common fragment of PCT-1 and PCT-2, while Clone 7 re-
acted to the unique part of PCT-1. 
 
 
Figure 3  Hybridomas positive in the first screen were detected in the 
second round by using each single GST-tagged protein. Positive hybrido-
mas against the respective antigen (Table S2 in Supporting Information) 
were organized and shown as column chart. 
 
Figure 4  Partial results of mono-specific clones (Table S3 in Supporting 
Information) in the second round of ELISA screening. 
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2.4  Comparison of the two media 
In order to compare the effect of semi-solid media and the 
classical liquid media in hybridoma generation, the fusion 
cells were cultured with these two kinds of media respec-
tively and evaluated in two rounds of ELISA screening as 
described. Three hundred and seventy-six wells cultured in 
semi-solid medium and 1880 wells cultured in liquid me-
dium (Table 2) were detected in the first round of screening. 
As the result, 26 wells (6.9%) from semi-solid media and 
103 wells (5.4%) from liquid media showed positive. The 
positive wells were tested in the second round screening. 
From these results, nine out of 26 wells cultured by 
semi-solid medium showed specificity to one, six, seven, 
and eight kinds of proteins, while 78 out of 103 wells cul-
tured by classical liquid medium showed specificity to one, 
two, three, four, five, and eight kinds of proteins (Table S4 
in Supporting Information; Table 2). These results are 
summarized in Figure 5. The hybridomas that only reacted 
to a single protein are called “mono-specific” hybridoma, 
those that reacted to multiple proteins, “poly-reactive” hy-
bridoma, and those that reacted to limited proteins, “oligo- 
reactive” hybridoma [13,14]. We have observed that the 
classical liquid medium cultured mono-reactive hybridomas, 
“oligo-reactive” hybridomas and poly-reactive hybridomas, 
while the semi-solid medium did not select the “oli-
go-reactive” hybridomas. 
2.5  Western blotting 
Specificity of the mono-specific hybridomas in ELISA was 
further verified by Western blotting, two irrelative proteins  
(MLH1, NP_000240.1 and Clu, NP_000305.3) were added 
as negative control (Figure 6). From the results, hybridomas 
mono-specific to five proteins (S100A8, S100A9, pCAF, 
PCT-1 and PCT-2) were verified. All antibodies reacted 
with a single antigen and did not cross-react with the other 
seven proteins. The antibody in Figure 6C showed positive 
for both PCT-1 and -2, suggesting the antibody is specific to 
the common fragment of PCT-1 and -2. Antigens TP53 and 
pCAF were partially degraded, which led to multiple bands 
in Western blotting (Figure 6D and E). 
3  Discussion 
Antibodies are an important tool in protein related research. 
Many countries and institutes have organized Ab related 
projects such as “ProteomeBinders”, a new European con-
sortium to establish a comprehensive resource of well- 
characterized affinity reagents, including antibodies [15]. 
The Human Proteome Organization has officially launched 
a global Human Proteome Project (HPP) designed to map 
the entire human protein set [1618]. HPP research groups 
will use the three working pillars for the project, one of 
which is the antibody capture pillar [19,20]. Consequently, 
the antibody/protein capture resource committee was estab-
lished in 2012. With the in-depth development of human 
proteomics, the project for preparation of antibodies against 
all human proteins has been mentioned in the agenda. 
However, the number of human proteins is enormous be-
cause of posttranslational modification, alternative splicing, 
mutation and so on. Moreover, each protein requires differ- 
 
 
Figure 5  Comparing the effect of liquid and semi-solid media to hybridoma generation. 
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Figure 6  After two rounds of ELISA screening, partial mono-specific clones were further identified in Western blot. All gels were loaded as follows: Lane 
1, MLH1; Lane 2, TP53; Lane 3, Myc; Lane 4, S100A8; Lane 5, S100A9; Lane 6, pCAF; Lane 7, Clu; Lane 8, PCT-1; Lane 9, PTEN; Lane 10, PCT-2. 
ent antibodies that are suitable for different applications 
(Western blotting, immunoprecipitation, immunohisto-
chemistry, immunofluorescence, flow cytometry, etc.). For 
these reasons, a high throughput method that can rapidly 
generate antibodies is urgently needed. In our previous re-
search, our group has immunized mice with four known 
proteins and screened for mAbs with ELISA and protein 
array [8]. In this study, we expanded the antigen set to eight 
kinds of proteins. For this project, we made efforts to gen-
erate mAbs that are characterized by both high throughput 
and fast immunization. We were able to produce hybrido-
mas specific against all immunized proteins verified by 
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ELLSA. However, we could not produce positive hybrido-
mas against c-Myc and PTEN that could be verified by 
Western-blotting. This is probably because c-Myc and 
PTEN induced only a weak immune-response in the mice 
(the antibody titers are all 1:100), resulting in very few spe-
cific B cells. Fusion cells were cultured both in liquid 
RPMI-1640 and semi-solid medium to compare the effect to 
hybridomas reactivity. The liquid medium cultured mono- 
reactive hybridomas, “oligo-reactive” hybridomas and 
poly-reactive hybridomas, while the semi-solid medium lost 
the “oligo-reactive” hybridomas. A multireactive antibody 
was reported in the preimmune repertoire that could bind to 
several unrelated antigens [21] and cause immunoassay 
interference [22]. An oligo-reactive Ab is the intermediate 
form when a poly-reactive Ab converts to mono-reactive Ab 
[13,14], suggesting that as an intermediate form during an-
tibody affinity maturation process, the hybridoma is not 
stable and is unable to survive in semi-solid medium. How-
ever, to some extent, this reduced workload is consistent 
with our initial goal.  
Here antigens S100A8 and S100A9 induced a large pro-
portion of positive clones that showed cross-reactivity to 
both of them (Table S2 in Supporting Information; Figure 
3). S100A8 and S100A9 are co-expressed in the event of 
acute or chronic inflammation, and form a hetero-dimer 
complex for functioning under physiological condition. It is 
reported that these two proteins have high similarity in spa-
tial conformation [23], which may cause many initially in-
duced antibodies not to distinguish them well. Compared to 
others, antigen pCAF induced more mono-specific clones 
when its high antigenicity is taken in consideration. Thus, to 
increase the variety of mono-reactive clones in the case of 
immunization of multiple antigens, antigenicity should be 
considered for inducing B-cells against the given immuno-
gen. Moreover, high homology in both amino acid sequence 
and spatial conformation of antigens should be avoided for 
properly rising of multi-reactive clones. Besides, from our 
results, the semi-solid medium may be a good way not only 
because of its selectivity for the “oligo-reactive clones”, but 
also because a single clone can be easily judged compared 
with the liquid medium. Thus, the “multi-reactive” caused 
by “multiple clones” can be quickly distinguished. For ob-
taining more mono-reactive clones, enough immune time is 
necessary. It is reported that polyreactive antibodies are the 
predominant antibodies produced by early B cell precursors 
and play a similar role in natural immunity [14], suggesting 
that most polyreactive antibodies may appear in the early 
stage of immunization. Therefore, our short immunization 
period of 10 d may not be enough for producing more 
mono-reactive antibodies. The aforementioned points may 
increase the possibility of getting sufficient monoclonal 
antibodies against each antigen. Such method that allows 
for antigen selection of multiple proteins and produces 
high-quality antibodies is essential to high throughput 
monoclonal antibody production.  
4  Conclusion 
We immunized mice with eight proteins important in re-
search and clinical use and obtained mAbs mono-specific to 
eight antigens in ELISA assay. Among them, mAbs against 
five antigens showed positive both in ELISA and West-
ern-blotting detection. This not only provides a reliable ap-
proach to high throughput monoclonal antibody production, 
but also saves time and labor costs in proteome research for 
identification of target proteins. 
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